{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:25:17Z","timestamp":1781727917089,"version":"3.54.5"},"reference-count":65,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French Agence Nationale de la Recherche grant for Laboratory of Excellence Ion Channels, Science and Therapeutics","doi-asserted-by":"publisher","award":["ANR-11-LABX-0015"],"award-info":[{"award-number":["ANR-11-LABX-0015"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French Agence Nationale de la Recherche grant for Laboratory of Excellence Ion Channels, Science and Therapeutics","doi-asserted-by":"publisher","award":["2016\u201311092\/11093"],"award-info":[{"award-number":["2016\u201311092\/11093"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9gion Pays de la Loire","award":["ANR-11-LABX-0015"],"award-info":[{"award-number":["ANR-11-LABX-0015"]}]},{"name":"R\u00e9gion Pays de la Loire","award":["2016\u201311092\/11093"],"award-info":[{"award-number":["2016\u201311092\/11093"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Natural peptides isolated from animal venoms generally target cell surface receptors with high affinity and selectivity. On many occasions, some of these receptors are over-expressed in cancer cells. Herein, we identified Lqh-8\/6 as a natural peptide analog of chlorotoxin, a proven and useful compound for the diagnosis and treatment of glioma. Lqh-8\/6 and two other natural analogues were chemically synthesized for the first time and evaluated for their ability to label, detect and prevent glioma growth in vitro. We demonstrate that a biotinylated version of Lqh-8\/6 allows both the labeling of glioma cell lines and the detection of glioma in brain sections of glioma allograft Fisher rats. Lqh-8\/6 has intrinsic anti-invasive properties but is non-toxic to glioma cells. To confer anti-tumor properties to Lqh-8\/6, we chemically coupled doxorubicin to the glioma-targeting peptide using click chemistry. To this end, we successfully chemically synthesized Lqh-8\/6-azide and doxorubicin-alkyne without impairing the toxic nature of doxorubicin. The toxin-drug conjugate efficiently promotes the apoptosis of glioma cells in vitro. This example contributes to the concept that animal venom peptides constitute exquisite warheads for delivering toxic chemical conjugates, a parallel to the popular concept of antibody-drug conjugates for the treatment of cancer.<\/jats:p>","DOI":"10.3390\/biomedicines10102605","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T21:11:51Z","timestamp":1666041111000},"page":"2605","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Conjugate between Lqh-8\/6, a Natural Peptide Analogue of Chlorotoxin, and Doxorubicin Efficiently Induces Glioma Cell Death"],"prefix":"10.3390","volume":"10","author":[{"given":"Lucie","family":"Dardevet","sequence":"first","affiliation":[{"name":"L\u2019institut du Thorax, Nantes Universit\u00e9, CNRS, INSERM, 44000 Nantes, France"},{"name":"LabEx \u201cIon Channels, Science & Therapeutics\u201d, 06560 Valbonne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feten","family":"Najlaoui","sequence":"additional","affiliation":[{"name":"Laboratoire des Venins et Biomol\u00e9cules Th\u00e9rapeutiques LR11IPT08, Institut Pasteur de Tunis, Tunis 1002, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Aroui","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Molecular Mechanisms and Diseases Research Unit, UR12ES08, Faculty of Medicine, University of Monastir, Monastir 09023, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-1730","authenticated-orcid":false,"given":"Mayeul","family":"Collot","sequence":"additional","affiliation":[{"name":"Laboratoire de Bioimagerie et Pathologies, UMR CNRS 7021, 74 route du rhin, CS 60024, 67401 Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Tisseyre","sequence":"additional","affiliation":[{"name":"LabEx \u201cIon Channels, Science & Therapeutics\u201d, 06560 Valbonne, France"},{"name":"Universit\u00e9 Grenoble Alpes, 621 Avenue Centrale, 38400 Saint-Martin d\u2019H\u00e8res, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5446-3447","authenticated-orcid":false,"given":"Michael W.","family":"Pennington","sequence":"additional","affiliation":[{"name":"Ambiopharm Inc., 1024 Dittman Crt, North Augusta, SC 29842, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8570-9542","authenticated-orcid":false,"given":"Jean-Maurice","family":"Mallet","sequence":"additional","affiliation":[{"name":"Laboratoire des Biomol\u00e9cules, Ecole Normale Sup\u00e9rieure, PSL University, Sorbonne University, CNRS UMR 7203, 75005 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2782-9615","authenticated-orcid":false,"given":"Michel","family":"De Waard","sequence":"additional","affiliation":[{"name":"L\u2019institut du Thorax, Nantes Universit\u00e9, CNRS, INSERM, 44000 Nantes, France"},{"name":"LabEx \u201cIon Channels, Science & Therapeutics\u201d, 06560 Valbonne, France"},{"name":"Smartox Biotechnology, 6 rue des Platanes, 38120 Saint-Egr\u00e8ve, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","article-title":"Glioblastoma","volume":"134","author":"Wirsching","year":"2016","journal-title":"Handb. Clin. Neurol."},{"key":"ref_2","unstructured":"(2022, September 01). Glioblastoma. Available online: http:\/\/www.abta.org\/brain-tumor-information\/types-of-tumors\/glioblastoma.html."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nec.2020.09.005","article-title":"Perioperative Management of Patients with Glioblastoma","volume":"32","author":"Garcia","year":"2021","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: A clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","article-title":"Human glioblastoma arises from subventricular zone cells with low-level driver mutations","volume":"560","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/cmi.2017.159","article-title":"Cellular origin of glioblastoma and its implication in precision therapy","volume":"15","author":"Yao","year":"2018","journal-title":"Cell Mol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","article-title":"Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma","volume":"57","author":"Ahir","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(03)12328-8","article-title":"Primary brain tumours in adults","volume":"361","author":"Behin","year":"2003","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PPO.0b013e318244d7c8","article-title":"Neuroimaging: Diagnosis and response assessment in glioblastoma","volume":"18","author":"Clarke","year":"2012","journal-title":"Cancer J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00701-011-1001-x","article-title":"Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: New arguments in an old discussion","volume":"153","author":"Stummer","year":"2011","journal-title":"Acta Neurochir."},{"key":"ref_11","first-page":"61","article-title":"New drugs and combinations for malignant glioma","volume":"13","author":"Stupp","year":"2003","journal-title":"Forum"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"x33","DOI":"10.1093\/annonc\/mds302","article-title":"Decision making and management of gliomas: Practical considerations","volume":"23","author":"Hottinger","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fonc.2015.00012","article-title":"Immunotherapeutic advancements for glioblastoma","volume":"5","author":"Ampie","year":"2015","journal-title":"Front. Oncol."},{"key":"ref_16","first-page":"1229","article-title":"Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme","volume":"35","author":"Okonogi","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"34ps26","DOI":"10.1126\/scitranslmed.3001174","article-title":"Tumor-penetrating peptides: A shift from magic bullets to magic guns","volume":"2","author":"Feron","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Savino, M., Annibali, D., Carucci, N., Favuzzi, E., Cole, M.D., Evan, G.I., Soucek, L., and Nasi, S. (2011). The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022284"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/0008-5472.CAN-12-1668","article-title":"De novo design of a tumor-penetrating peptide","volume":"73","author":"Alberici","year":"2013","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/toxins7041079","article-title":"Chlorotoxin: A helpful natural scorpion peptide to diagnose glioma and fight tumor invasion","volume":"7","author":"Dardevet","year":"2015","journal-title":"Toxins"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/bj20031860","article-title":"Diversity of folds in animal toxins acting on ion channels","volume":"378","author":"Mouhat","year":"2004","journal-title":"Biochem. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am. J. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0041-0101(91)90128-E","article-title":"Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus","volume":"29","author":"DeBin","year":"1991","journal-title":"Toxicon"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/smll.200800646","article-title":"Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles","volume":"5","author":"Veiseh","year":"2009","journal-title":"Small"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1523\/JNEUROSCI.19-14-05942.1999","article-title":"Modulation of glioma cell migration and invasion using Cl\u2212 and K+ ion channel blockers","volume":"19","author":"Soroceanu","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0306-4522(97)00456-9","article-title":"Expression of voltage-activated chloride currents in acute slices of human gliomas","volume":"83","author":"Ullrich","year":"1998","journal-title":"Neuroscience"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.23-13-05572.2003","article-title":"Expression of voltage-gated chloride channels in human glioma cells","volume":"23","author":"Olsen","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_29","first-page":"4871","article-title":"Use of chlorotoxin for targeting of primary brain tumors","volume":"58","author":"Soroceanu","year":"1998","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/glia.10083","article-title":"Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin","volume":"39","author":"Lyons","year":"2002","journal-title":"Glia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1074\/jbc.M109.066092","article-title":"Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects","volume":"285","author":"Kesavan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: A chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/nn1008512","article-title":"Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma","volume":"4","author":"Kievit","year":"2010","journal-title":"ACS Nano"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.biomaterials.2008.10.003","article-title":"A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells","volume":"30","author":"Veiseh","year":"2009","journal-title":"Biomaterials"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.biomaterials.2010.11.079","article-title":"Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration","volume":"32","author":"Huang","year":"2011","journal-title":"Biomaterials"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/nl0502569","article-title":"Optical and MRI multifunctional nanoprobe for targeting gliomas","volume":"5","author":"Veiseh","year":"2005","journal-title":"Nano Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/jm101018r","article-title":"Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy","volume":"54","author":"Akcan","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jinorgbio.2012.02.012","article-title":"Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells","volume":"110","author":"Graf","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1081\/TXR-100108558","article-title":"Toxin evolution in scorpion venom: Evidence for toxin divergence under strong negative selection in Leiurus quinquestriatus subspecies","volume":"20","author":"Smertenko","year":"2001","journal-title":"J. Toxicol. Toxin Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xu, T., Fan, Z., Li, W., Dietel, B., Wu, Y., Beckmann, M.W., Wrosch, J.K., Buchfelder, M., Eyupoglu, I.Y., and Cao, Z. (2016). Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Sci. Rep., 6.","DOI":"10.1038\/srep19799"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.canlet.2009.10.011","article-title":"BmKCT toxin inhibits glioma proliferation and tumor metastasis","volume":"291","author":"Fan","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"W485","DOI":"10.1093\/nar\/gkp368","article-title":"@TOME-2: A new pipeline for comparative modeling of protein-ligand complexes","volume":"37","author":"Pons","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1432-1033.1997.00218.x","article-title":"Solution structure of Lqh-8\/6, a toxin-like peptide from a scorpion venom\u2014Structural heterogeneity induced by proline cis\/trans isomerization","volume":"246","author":"Adjadj","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.bbamcr.2014.03.017","article-title":"Quantitative evaluation of the cell penetrating properties of an iodinated Tyr-L-maurocalcine analog","volume":"1843","author":"Tisseyre","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.bmcl.2005.07.087","article-title":"Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity","volume":"15","author":"Liang","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/jm9016637","article-title":"New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration","volume":"53","author":"Che","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.1021\/jm0606591","article-title":"Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell)","volume":"49","author":"Quinonero","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/mp100243j","article-title":"Biological evaluation of a novel doxorubicin-peptide conjugate for targeted delivery to EGF receptor-overexpressing tumor cells","volume":"8","author":"Ai","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/mol.57.4.679","article-title":"New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy","volume":"57","author":"Rousselle","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.peptides.2011.01.015","article-title":"Purification, synthesis and characterization of AaCtx, the first chlorotoxin-like peptide from Androctonus australis scorpion venom","volume":"32","author":"Rjeibi","year":"2011","journal-title":"Peptides"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1039\/C5TB02123E","article-title":"Gemcitabine and Chlorotoxin Conjugated Iron Oxide Nanoparticles for Glioblastoma Therapy","volume":"4","author":"Mu","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1021\/acsnano.5b07375","article-title":"A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma","volume":"10","author":"Tamborini","year":"2016","journal-title":"ACS Nano"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2174\/1568026615666150330110822","article-title":"Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma","volume":"15","author":"Zhao","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11060-011-0763-6","article-title":"Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs","volume":"107","author":"Fu","year":"2012","journal-title":"J. Neurooncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00687318","article-title":"Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: And experimental study in the rat","volume":"29","author":"Yeung","year":"1991","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/153303460800700611","article-title":"Recent advances in protection against doxorubicin-induced toxicity","volume":"7","author":"Injac","year":"2008","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1021\/acs.molpharmaceut.5b00531","article-title":"A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK\/AKT-p53 Pathway","volume":"12","author":"Aroui","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2009.04.044","article-title":"Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231","volume":"285","author":"Aroui","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10495-009-0397-8","article-title":"Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis","volume":"14","author":"Aroui","year":"2009","journal-title":"Apoptosis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbrc.2009.11.073","article-title":"Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: A comparative study","volume":"391","author":"Aroui","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biocel.2016.05.013","article-title":"PTEN-regulated AKT\/FoxO3a\/Bim signaling contributes to Human cell glioblastoma apoptosis by platinum-maurocalcin conjugate","volume":"77","author":"Aroui","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbrc.2010.05.020","article-title":"Doxorubicin coupled to penetratin promotes apoptosis in CHO cells by a mechanism involving c-Jun NH2-terminal kinase","volume":"396","author":"Aroui","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s11095-008-9782-1","article-title":"Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231","volume":"26","author":"Aroui","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"27730","DOI":"10.3390\/ijms161126054","article-title":"Biodistribution, Stability, and Blood Distribution of the Cell Penetrating Peptide Maurocalcine in Mice","volume":"16","author":"Perret","year":"2015","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2605\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:54Z","timestamp":1760144154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":65,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biomedicines10102605"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10102605","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}